カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の百日咳予防接種市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Pertussis Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19526）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19526
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の百日咳予防接種市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

百日咳予防接種市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の百日咳予防接種の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

百日咳予防接種市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・無細胞ワクチン、全細胞ワクチン

用途別セグメントは次のように区分されます。
・12ヶ月下、12ヶ月上

世界の百日咳予防接種市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi Pasteur、GSK、Mitsubishi Tanabe Pharma、KM Biologics、Wuhan Institute of Biological Products、Walvax Biotechnology、Chengdu Institute of Biological Products、Minhai Biotechnology

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、百日咳予防接種製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な百日咳予防接種メーカーの企業概要、2019年～2022年までの百日咳予防接種の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な百日咳予防接種メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別百日咳予防接種の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの百日咳予防接種の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での百日咳予防接種市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および百日咳予防接種の産業チェーンを掲載しています。
・第13、14、15章では、百日咳予防接種の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 百日咳予防接種の概要
- 種類別分析（2017年vs2021年vs2028年）：無細胞ワクチン、全細胞ワクチン
- 用途別分析（2017年vs2021年vs2028年）：12ヶ月下、12ヶ月上
- 世界の百日咳予防接種市場規模・予測
- 世界の百日咳予防接種生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Sanofi Pasteur、GSK、Mitsubishi Tanabe Pharma、KM Biologics、Wuhan Institute of Biological Products、Walvax Biotechnology、Chengdu Institute of Biological Products、Minhai Biotechnology
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：無細胞ワクチン、全細胞ワクチン
・用途別分析2017年-2028年：12ヶ月下、12ヶ月上
・百日咳予防接種の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・百日咳予防接種のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・百日咳予防接種のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・百日咳予防接種の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・百日咳予防接種の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pertussis Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pertussis Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. 12 Months Below accounting for % of the Pertussis Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Acellular Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pertussis Vaccination include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, and Wuhan Institute of Biological Products, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pertussis Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Acellular Vaccines
Whole-cell Vaccines
Market segment by Application can be divided into
12 Months Below
12 Months Above
The key market players for global Pertussis Vaccination market are listed below:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pertussis Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pertussis Vaccination, with price, sales, revenue and global market share of Pertussis Vaccination from 2019 to 2022.
Chapter 3, the Pertussis Vaccination competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pertussis Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pertussis Vaccination market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pertussis Vaccination.
Chapter 13, 14, and 15, to describe Pertussis Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Pertussis Vaccination Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pertussis Vaccination Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Acellular Vaccines
1.2.3 Whole-cell Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Pertussis Vaccination Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global Pertussis Vaccination Market Size & Forecast
1.4.1 Global Pertussis Vaccination Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pertussis Vaccination Sales in Volume (2017-2028)
1.4.3 Global Pertussis Vaccination Price (2017-2028)
1.5 Global Pertussis Vaccination Production Capacity Analysis
1.5.1 Global Pertussis Vaccination Total Production Capacity (2017-2028)
1.5.2 Global Pertussis Vaccination Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pertussis Vaccination Market Drivers
1.6.2 Pertussis Vaccination Market Restraints
1.6.3 Pertussis Vaccination Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Pertussis Vaccination Product and Services
2.1.4 Sanofi Pasteur Pertussis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Pertussis Vaccination Product and Services
2.2.4 GSK Pertussis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mitsubishi Tanabe Pharma
2.3.1 Mitsubishi Tanabe Pharma Details
2.3.2 Mitsubishi Tanabe Pharma Major Business
2.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccination Product and Services
2.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 KM Biologics
2.4.1 KM Biologics Details
2.4.2 KM Biologics Major Business
2.4.3 KM Biologics Pertussis Vaccination Product and Services
2.4.4 KM Biologics Pertussis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Wuhan Institute of Biological Products
2.5.1 Wuhan Institute of Biological Products Details
2.5.2 Wuhan Institute of Biological Products Major Business
2.5.3 Wuhan Institute of Biological Products Pertussis Vaccination Product and Services
2.5.4 Wuhan Institute of Biological Products Pertussis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Walvax Biotechnology
2.6.1 Walvax Biotechnology Details
2.6.2 Walvax Biotechnology Major Business
2.6.3 Walvax Biotechnology Pertussis Vaccination Product and Services
2.6.4 Walvax Biotechnology Pertussis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Chengdu Institute of Biological Products
2.7.1 Chengdu Institute of Biological Products Details
2.7.2 Chengdu Institute of Biological Products Major Business
2.7.3 Chengdu Institute of Biological Products Pertussis Vaccination Product and Services
2.7.4 Chengdu Institute of Biological Products Pertussis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Minhai Biotechnology
2.8.1 Minhai Biotechnology Details
2.8.2 Minhai Biotechnology Major Business
2.8.3 Minhai Biotechnology Pertussis Vaccination Product and Services
2.8.4 Minhai Biotechnology Pertussis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pertussis Vaccination Breakdown Data by Manufacturer
3.1 Global Pertussis Vaccination Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pertussis Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pertussis Vaccination
3.4 Market Concentration Rate
3.4.1 Top 3 Pertussis Vaccination Manufacturer Market Share in 2021
3.4.2 Top 6 Pertussis Vaccination Manufacturer Market Share in 2021
3.5 Global Pertussis Vaccination Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pertussis Vaccination Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pertussis Vaccination Market Size by Region
4.1.1 Global Pertussis Vaccination Sales in Volume by Region (2017-2028)
4.1.2 Global Pertussis Vaccination Revenue by Region (2017-2028)
4.2 North America Pertussis Vaccination Revenue (2017-2028)
4.3 Europe Pertussis Vaccination Revenue (2017-2028)
4.4 Asia-Pacific Pertussis Vaccination Revenue (2017-2028)
4.5 South America Pertussis Vaccination Revenue (2017-2028)
4.6 Middle East and Africa Pertussis Vaccination Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pertussis Vaccination Sales in Volume by Type (2017-2028)
5.2 Global Pertussis Vaccination Revenue by Type (2017-2028)
5.3 Global Pertussis Vaccination Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pertussis Vaccination Sales in Volume by Application (2017-2028)
6.2 Global Pertussis Vaccination Revenue by Application (2017-2028)
6.3 Global Pertussis Vaccination Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pertussis Vaccination Sales by Type (2017-2028)
7.2 North America Pertussis Vaccination Sales by Application (2017-2028)
7.3 North America Pertussis Vaccination Market Size by Country
7.3.1 North America Pertussis Vaccination Sales in Volume by Country (2017-2028)
7.3.2 North America Pertussis Vaccination Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pertussis Vaccination Sales by Type (2017-2028)
8.2 Europe Pertussis Vaccination Sales by Application (2017-2028)
8.3 Europe Pertussis Vaccination Market Size by Country
8.3.1 Europe Pertussis Vaccination Sales in Volume by Country (2017-2028)
8.3.2 Europe Pertussis Vaccination Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pertussis Vaccination Sales by Type (2017-2028)
9.2 Asia-Pacific Pertussis Vaccination Sales by Application (2017-2028)
9.3 Asia-Pacific Pertussis Vaccination Market Size by Region
9.3.1 Asia-Pacific Pertussis Vaccination Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pertussis Vaccination Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pertussis Vaccination Sales by Type (2017-2028)
10.2 South America Pertussis Vaccination Sales by Application (2017-2028)
10.3 South America Pertussis Vaccination Market Size by Country
10.3.1 South America Pertussis Vaccination Sales in Volume by Country (2017-2028)
10.3.2 South America Pertussis Vaccination Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pertussis Vaccination Sales by Type (2017-2028)
11.2 Middle East & Africa Pertussis Vaccination Sales by Application (2017-2028)
11.3 Middle East & Africa Pertussis Vaccination Market Size by Country
11.3.1 Middle East & Africa Pertussis Vaccination Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pertussis Vaccination Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pertussis Vaccination and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pertussis Vaccination
12.3 Pertussis Vaccination Production Process
12.4 Pertussis Vaccination Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pertussis Vaccination Typical Distributors
13.3 Pertussis Vaccination Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Pertussis Vaccination Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pertussis Vaccination Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Pertussis Vaccination Product and Services
Table 6. Sanofi Pasteur Pertussis Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Pertussis Vaccination Product and Services
Table 10. GSK Pertussis Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Mitsubishi Tanabe Pharma Major Business
Table 13. Mitsubishi Tanabe Pharma Pertussis Vaccination Product and Services
Table 14. Mitsubishi Tanabe Pharma Pertussis Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 16. KM Biologics Major Business
Table 17. KM Biologics Pertussis Vaccination Product and Services
Table 18. KM Biologics Pertussis Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 20. Wuhan Institute of Biological Products Major Business
Table 21. Wuhan Institute of Biological Products Pertussis Vaccination Product and Services
Table 22. Wuhan Institute of Biological Products Pertussis Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Walvax Biotechnology Major Business
Table 25. Walvax Biotechnology Pertussis Vaccination Product and Services
Table 26. Walvax Biotechnology Pertussis Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 28. Chengdu Institute of Biological Products Major Business
Table 29. Chengdu Institute of Biological Products Pertussis Vaccination Product and Services
Table 30. Chengdu Institute of Biological Products Pertussis Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 32. Minhai Biotechnology Major Business
Table 33. Minhai Biotechnology Pertussis Vaccination Product and Services
Table 34. Minhai Biotechnology Pertussis Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Pertussis Vaccination Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
Table 36. Global Pertussis Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Pertussis Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Pertussis Vaccination Production Capacity by Company, (Units): 2020 VS 2021
Table 39. Head Office and Pertussis Vaccination Production Site of Key Manufacturer
Table 40. Pertussis Vaccination New Entrant and Capacity Expansion Plans
Table 41. Pertussis Vaccination Mergers & Acquisitions in the Past Five Years
Table 42. Global Pertussis Vaccination Sales by Region (2017-2022) & (Units)
Table 43. Global Pertussis Vaccination Sales by Region (2023-2028) & (Units)
Table 44. Global Pertussis Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Pertussis Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 47. Global Pertussis Vaccination Sales by Type (2023-2028) & (Units)
Table 48. Global Pertussis Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Pertussis Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Pertussis Vaccination Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Pertussis Vaccination Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 53. Global Pertussis Vaccination Sales by Application (2023-2028) & (Units)
Table 54. Global Pertussis Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Pertussis Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Pertussis Vaccination Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Pertussis Vaccination Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Pertussis Vaccination Sales by Country (2017-2022) & (Units)
Table 59. North America Pertussis Vaccination Sales by Country (2023-2028) & (Units)
Table 60. North America Pertussis Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Pertussis Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 63. North America Pertussis Vaccination Sales by Type (2023-2028) & (Units)
Table 64. North America Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 65. North America Pertussis Vaccination Sales by Application (2023-2028) & (Units)
Table 66. Europe Pertussis Vaccination Sales by Country (2017-2022) & (Units)
Table 67. Europe Pertussis Vaccination Sales by Country (2023-2028) & (Units)
Table 68. Europe Pertussis Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Pertussis Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 71. Europe Pertussis Vaccination Sales by Type (2023-2028) & (Units)
Table 72. Europe Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 73. Europe Pertussis Vaccination Sales by Application (2023-2028) & (Units)
Table 74. Asia-Pacific Pertussis Vaccination Sales by Region (2017-2022) & (Units)
Table 75. Asia-Pacific Pertussis Vaccination Sales by Region (2023-2028) & (Units)
Table 76. Asia-Pacific Pertussis Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Pertussis Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 79. Asia-Pacific Pertussis Vaccination Sales by Type (2023-2028) & (Units)
Table 80. Asia-Pacific Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 81. Asia-Pacific Pertussis Vaccination Sales by Application (2023-2028) & (Units)
Table 82. South America Pertussis Vaccination Sales by Country (2017-2022) & (Units)
Table 83. South America Pertussis Vaccination Sales by Country (2023-2028) & (Units)
Table 84. South America Pertussis Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Pertussis Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 87. South America Pertussis Vaccination Sales by Type (2023-2028) & (Units)
Table 88. South America Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 89. South America Pertussis Vaccination Sales by Application (2023-2028) & (Units)
Table 90. Middle East & Africa Pertussis Vaccination Sales by Region (2017-2022) & (Units)
Table 91. Middle East & Africa Pertussis Vaccination Sales by Region (2023-2028) & (Units)
Table 92. Middle East & Africa Pertussis Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Pertussis Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 95. Middle East & Africa Pertussis Vaccination Sales by Type (2023-2028) & (Units)
Table 96. Middle East & Africa Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 97. Middle East & Africa Pertussis Vaccination Sales by Application (2023-2028) & (Units)
Table 98. Pertussis Vaccination Raw Material
Table 99. Key Manufacturers of Pertussis Vaccination Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Pertussis Vaccination Typical Distributors
Table 103. Pertussis Vaccination Typical Customers
List of Figures
Figure 1. Pertussis Vaccination Picture
Figure 2. Global Pertussis Vaccination Revenue Market Share by Type in 2021
Figure 3. Acellular Vaccines
Figure 4. Whole-cell Vaccines
Figure 5. Global Pertussis Vaccination Revenue Market Share by Application in 2021
Figure 6. 12 Months Below
Figure 7. 12 Months Above
Figure 8. Global Pertussis Vaccination Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
Figure 9. Global Pertussis Vaccination Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Pertussis Vaccination Sales (2017-2028) & (Units)
Figure 11. Global Pertussis Vaccination Price (2017-2028) & (US$/Unit)
Figure 12. Global Pertussis Vaccination Production Capacity (2017-2028) & (Units)
Figure 13. Global Pertussis Vaccination Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Pertussis Vaccination Market Drivers
Figure 15. Pertussis Vaccination Market Restraints
Figure 16. Pertussis Vaccination Market Trends
Figure 17. Global Pertussis Vaccination Sales Market Share by Manufacturer in 2021
Figure 18. Global Pertussis Vaccination Revenue Market Share by Manufacturer in 2021
Figure 19. Pertussis Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Pertussis Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Pertussis Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Pertussis Vaccination Sales Market Share by Region (2017-2028)
Figure 23. Global Pertussis Vaccination Revenue Market Share by Region (2017-2028)
Figure 24. North America Pertussis Vaccination Revenue (2017-2028) & (USD Million)
Figure 25. Europe Pertussis Vaccination Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Pertussis Vaccination Revenue (2017-2028) & (USD Million)
Figure 27. South America Pertussis Vaccination Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Pertussis Vaccination Revenue (2017-2028) & (USD Million)
Figure 29. Global Pertussis Vaccination Sales Market Share by Type (2017-2028)
Figure 30. Global Pertussis Vaccination Revenue Market Share by Type (2017-2028)
Figure 31. Global Pertussis Vaccination Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Pertussis Vaccination Sales Market Share by Application (2017-2028)
Figure 33. Global Pertussis Vaccination Revenue Market Share by Application (2017-2028)
Figure 34. Global Pertussis Vaccination Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Pertussis Vaccination Sales Market Share by Type (2017-2028)
Figure 36. North America Pertussis Vaccination Sales Market Share by Application (2017-2028)
Figure 37. North America Pertussis Vaccination Sales Market Share by Country (2017-2028)
Figure 38. North America Pertussis Vaccination Revenue Market Share by Country (2017-2028)
Figure 39. United States Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Pertussis Vaccination Sales Market Share by Type (2017-2028)
Figure 43. Europe Pertussis Vaccination Sales Market Share by Application (2017-2028)
Figure 44. Europe Pertussis Vaccination Sales Market Share by Country (2017-2028)
Figure 45. Europe Pertussis Vaccination Revenue Market Share by Country (2017-2028)
Figure 46. Germany Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Pertussis Vaccination Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Pertussis Vaccination Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Pertussis Vaccination Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Pertussis Vaccination Revenue Market Share by Region (2017-2028)
Figure 55. China Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Pertussis Vaccination Sales Market Share by Type (2017-2028)
Figure 62. South America Pertussis Vaccination Sales Market Share by Application (2017-2028)
Figure 63. South America Pertussis Vaccination Sales Market Share by Country (2017-2028)
Figure 64. South America Pertussis Vaccination Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Pertussis Vaccination Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Pertussis Vaccination Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Pertussis Vaccination Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Pertussis Vaccination Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Pertussis Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Pertussis Vaccination in 2021
Figure 76. Manufacturing Process Analysis of Pertussis Vaccination
Figure 77. Pertussis Vaccination Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 百日咳菌検査キットのグローバル市場展望 2023年-2029年：診断用百日咳菌検査キット、研究用百日咳菌検査キット
  • 無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル市場展望 2023年-2029年：0.5mL用量、1.5mL用量
  • 世界のジフテリア破傷風百日せきワクチン市場2022年：市場規模予測（～2028年）
  • 世界の肺炎球菌ワクチン接種市場2022年：市場規模予測（～2028年）
  • ジフテリア/破傷風/百日咳（DPT）ワクチンのグローバル市場展望 2023年-2029年：DTwP型、DTaP型
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19526 )"世界の百日咳予防接種市場2022年：市場規模予測（～2028年）" (英文：Global Pertussis Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。